Fentora
Fentora is a potent, rapid-acting opioid analgesic containing fentanyl citrate, formulated as an effervescent buccal tablet. It utilizes a special drug delivery system that alters local pH to enhance absorption directly through the oral mucosa, bypassing first-pass metabolism for rapid onset of pain relief.
Dosage by Body Weight
Initial dose is always 100 mcg. Individually titrate to a tolerable dose that provides adequate analgesia. Limit use to treat no more than four episodes of breakthrough pain per day. Patients must wait at least 4 hours before treating another episode of breakthrough pain with Fentora. Safety and efficacy in pediatric patients under 18 years of age have not been established.
- Body Weight
- Below 5 kg
- Dose
- Contraindicated / Not recommended
- Frequency
- N/A
- Tracking Notes
- Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight.
- Body Weight
- 5-7 kg
- Dose
- Contraindicated / Not recommended
- Frequency
- N/A
- Tracking Notes
- Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight.
- Body Weight
- 8-10 kg
- Dose
- Contraindicated / Not recommended
- Frequency
- N/A
- Tracking Notes
- Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight.
- Body Weight
- 11-15 kg
- Dose
- Contraindicated / Not recommended
- Frequency
- N/A
- Tracking Notes
- Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight.
- Body Weight
- 16-20 kg
- Dose
- Contraindicated / Not recommended
- Frequency
- N/A
- Tracking Notes
- Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Contraindicated / Not recommended | N/A | Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight. |
| 5-7 kg | Contraindicated / Not recommended | N/A | Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight. |
| 8-10 kg | Contraindicated / Not recommended | N/A | Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight. |
| 11-15 kg | Contraindicated / Not recommended | N/A | Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight. |
| 16-20 kg | Contraindicated / Not recommended | N/A | Fentora is not indicated for pediatric patients. Dosing is exclusively based on titration and opioid tolerance, not body weight. |
Formulation
Purpose
Management of breakthrough pain in cancer patients (18 years of age and older) who are already receiving and who are tolerant to around-the-clock opioid therapy for their underlying persistent cancer pain.
Generic Name
Fentanyl citrateScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.